Background Biochemical MRI of hip cartilage such as delayed gadolinium-enhanced MRI of cartilage (dGEM-RIC) and T2 mapping is increasingly used to judge cartilage quality in the assessment of femoroacetabular impingement (FAI). The current evidence is sparse about which of these techniques yields a stronger correlation with histologic cartilage degeneration because of the difficulty in validating biochemical MRI techniques against histology in the clinical setting. Recently, an experimental ovine FAI model was established that induces chondrolabral damage and offers a validated platform to address these limitations. Questions/purposes In a sheep model, we asked: (1) Do dGEMRIC and/or T2 values of acetabular and femoral cartilage correlate with histologic cartilage degeneration as assessed with the Mankin score? (2) Do simultaneously measured dGEMRIC and T2 values correlate in an experimental ovine FAI model? Methods We performed an experimental pilot study on five female Swiss Alpine sheep (10 hips) that underwent postmortem MRI, including biochemical cartilage sequences, after a staged FAI correction had been performed on one side. No surgery was performed on the contralateral side, which The institution of one or more of the authors (BvR) has received, during the study period, funding from the Swiss National Science Foundation. One of the authors certifies that he (FS), or a member of his immediate family, has received or may receive grants, during the study period, in an amount of USD 10,000 to USD 100,000 from the Swiss National Science Foundation (Bern, Switzerland), outside the submitted work. One of the authors certifies that he (MT), or a member of his immediate family, has received or may receive grants, during the study period, in an amount of more than USD 1,000,001 from the Swiss National Science Foundation for the conduct of this work. Clinical Orthopaedics and Related Research® neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA approval status, of any drug or device before clinical use. Each author certifies that his or her institution approved the animal protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.